What are PPI heartburn drugs?
A proton pump inhibitor (PPI) is a drug used to reduce the production of stomach acid giving the esophagus, stomach, and duodenum (first part of the intestines) time to heal from irritation and erosive damage. The decrease in acid production will also help reduce acid reflux related heartburn.
Stomach acids are necessary for the proper digestion of our foods. But stomach acid can erode the body when not contained in its proper place. The stomach has a protective mucous barrier that protects its lining. When this mucous barrier is compromised, acid can eat away at the stomach causing ulcers. If stomach acid refluxes into the esophagus, irritation occurs. The esophagus doesn’t have a mucus barrier to withstand acid like the stomach. This irritation is the cause of heartburn. If left untreated, erosion of the esophagus may occur.
PPIs are the strongest inhibitors of acid available but are not used for immediate relief of heartburn. It may take days before a PPI will start providing relief from acid irritation. Relief will vary depending on the reason for taking the drug and the rate at which the body heals. If taking to treat an ulcer, relief may take longer.
PPIs are available in prescription and over the counter (OTC) versions. PPIs include:
- AcipHex (rabeprazole)
- Dexilant (dexlansoprazole)
- Kapidex (dexlansoprazole)
- Losec (omeprazole)
- Nexium (esomeprazole)
- Prevacid (lansoprazole)
- Prilosec (omeprazole)
- Protonix (pantoprazole)
- Rapinex (omeprazole)
- Vimovo (esomeprazole, magnesium, and naproxen)
- Zegerid (omeprazole and sodium bicarbonate)
What Digestive Issues are Treated with PPI therapy?
- PPIs are used to treat damage to the lower esophagus caused by acid reflux and gastroesophageal reflux disease (GERD).1
- PPIs are used to relieve GERD symptoms and prevent further complications of GERD.
- PPIs are used to treat erosive esophagitis.
- PPIs are used for maintenance to prevent esophagitis from recurring after the esophagus has healed.
- PPIs are used to treat Barrett’s esophagus.
- PPIs are used to treat esophageal, gastric, and duodenal ulcers by reducing acid allowing ulcers to heal.
- PPIs are used in combination with antibiotics for eliminating Helicobacter pylori (H. pylori), which can contribute to the formation of esophageal, gastric, and duodenal ulcers.
- PPIs are used for excessive gastrointestinal acid secretory disorders.
How to Take PPIs
PPIs are taken by mouth as tablets or capsules with a glass of water before the first meal of the day. It is important to drink the water along with the pill. Not drinking enough water can prevent it from working properly.
Talk with your doctor to know if you should take a PPI and for how long. Though available in OTC form, PPIs should not be taken without direction from your doctor. Your doctor may prescribe you a PPI for different time intervals depending on your health issue. The packaging on OTC PPIs clearly states to take it for no longer than 14 days or more often than every 4 months unless directed by a doctor. This is to prevent negative side effects that can occur when using the medication long term.
What are the PPI side effects and precautions?
PPIs are for temporary use and not intended for long-term daily use. When taken properly, they can be an effective treatment option. Long-term use, however, may lead to serious complications.
Please see the warnings that come with your particular PPI for a full list of possible side effects and precautions.
Common side effects found in temporary use are:
- Abdominal pain
Precautions when taking a PPI:
Tell your doctor or pharmacist if you are taking other medicines. PPIs can cause serious drug interaction issues. PPIs also reduce stomach acid needed to break down certain medications, thus affecting their absorption.
PPIs may not be advised if you are taking:
- Certain anti-seizure medicines such as phenytoin
- Blood thinners such as warfarin, clopidogrel, or cilostazol
- Prescription antifungal or anti-yeast medicines
- Diazepam (anxiety medicine)
- Digoxin (heart medicine)
- Tacrolimus (immune system medicine)
- Prescription antiretrovirals (medicines for HIV infection)
Specific precautions for women:
- If you are breastfeeding, pregnant, or may become pregnant, talk to your health care provider before taking these medicines. They expose the baby to some level of risk, though it is considered minimal.2
Precautions when using long term:
- Long-term use may lead to a 16 to 20 percent increase risk of heart attack depending on which PPI you are taking.3
- PPIs increase risk of chronic kidney disease.
- PPIs increase risk of liver damage.
- PPIs increase risk of pneumonia.
- PPIs increase risk of death.
- Stomach acid is beneficial in killing harmful bacteria introduced to the body through foods.
- There is increased risk of having an Clostridium difficile infection, a bacteria that causes persistent diarrhea.4
- Inefficient digestion leads to decreased absorption of vitamin B12, calcium, magnesium, iron and other nutrients.
- Higher levels of acids are useful in closing the lower esophageal sphincter (LES). When the LES is tightening properly, it prevents acid from refluxing into the esophagus.
- Increased risk of Barrett’s esophagus.7
- Getting off PPIs after long-term use can cause a painful rebound in acid. Weaning off PPIs is advisable.
1) Jai Moo Shin, PhD, & George Sachs, DSc, MD. “Pharmacology of Proton Pump Inhibitors.” National Center for Biotechnology Information, U.S. National Library of Medicine, Current Gastroenterology Reports – Springer, April 15, 2010.
2) Majithia R, & Johnson DA. “Are proton pump inhibitors safe during pregnancy and lactation? Evidence to date.” National Center for Biotechnology Information, U.S. National Library of Medicine, January 22, 2012.
3) Shah NH, LePendu P, Bauer-Mehren A, Ghebremariam YT, Iyer SV, Marcus J, Nead KT, Cooke JP, & Leeper NJ. “Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population.” National Center for Biotechnology Information, U.S. National Library of Medicine, PLOS One, June 10, 2015.
4) “FDA Drug Safety Communication: Clostridium difficile associated diarrhea can be associated with stomach acid drugs known as proton pump inhibitors (PPIs).” U.S. Food & Drug Administration, February 8, 2012.
5) “FDA Drug Safety Communication: Possible increased risk of fractures of the hip, wrist, and spine with the use of proton pump inhibitors.” U.S. Food & Drug Administration, March 23, 2011.
6) “FDA Drug Safety Communication: Low magnesium levels can be associated with long-term use of Proton Pump Inhibitor drugs (PPIs).” U.S. Food & Drug Administration, March 2, 2011.
7) Omran Alsalahi1, & Anca D. Dobrian. “Proton Pump Inhibitors: The Culprit for Barrett’s Esophagus?.” National Center for Biotechnology Information, U.S. National Library of Medicine, Frontiers in Oncology, January 9, 2015.